Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
Y W LeeC-H WonK JungH-J NamG ChoiY-H ParkMi-Young ParkB KimPublished in: The British journal of dermatology (2019)
PAC-14028 cream may be an effective and safe treatment modality for the treatment of patients with mild-to-moderate AD.
Keyphrases